Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells
β Scribed by Jian-ping Zou; Jun Shimizu; Kazuhiro Ikegame; Hidekazu Takiuchi; Hiromi Fujiwara; Toshiyuki Hamaoka
- Publisher
- Springer-Verlag
- Year
- 1992
- Tongue
- English
- Weight
- 751 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Vaccination with peptides isolated from tumor cells circumvents the need for identifying specific tumor rejection antigens and extends the use of active immunotherapy to the majority of cancers where specific tumor antigens have not yet been identified. In this study, we examined the efficacy of tum
C-type lectin receptors on antigen-presenting cells are potent antigen-uptake receptors with specificity for glycan structures. Glycosylation changes during malignant transformation create tumor-specific carbohydrate structures that interact with C-type lectins on dendritic cells. Recent findings re
Vaccination with tumor extracts circumvents the need to identify specific tumor rejection antigens and extends the use of active immunotherapy to the vast majority of cancers, in which specific tumor antigens have not yet been identified. In this study we examined the efficacy of tumor vaccines comp